Recent Posts

Dutch gene-therapy firm UniQure explores options including sale

Bloomberg UniQure NV is exploring options including a potential sale amid interest from pharmaceutical companies looking to expand in gene therapy, people with knowledge of the matter said. The shares jumped in early trading. The biotechnology company is working with advisers as it weighs options including a sale or partnerships, according to the people, who asked not to be identified ...

Read More »

Broadcom slides on dim sales outlook

Bloomberg Broadcom Inc. shares tumbled after the chipmaker cut its full-year sales outlook, citing the impact of the trade war between China and the US. While the weaker guidance didn’t come as a shock, the scale of the reduction caught some analysts off guard, and it was seen as further diminishing the idea that semiconductor demand would rebound in the ...

Read More »

US yields can tumble to 1.75% on trade meltdown

Bloomberg Treasury 10-year yields may drop to 1.75 percent by year-end if the US-China trade war goes full throttle, says Western Asset Management. Yields may keep falling even though they have already tumbled to about 2.10 percent from a seven-year high of 3.26 percent set in October, according to portfolio manager Mark Lindbloom. The trigger: a cocktail of lower inflation, ...

Read More »
Send this to a friend